Explainable Artificial Intelligence for Patient Safety A Review of Application in Pharmacovigilance. Shakas Technologies ( Galaxy of Knowledge) #11/A 2nd East Main Road, Gandhi Nagar, Vellore - 632006. Mobile : +91-9500218218 / 8220150373| land line- 0416- 3552723 Shakas Training & Development | Shakas Sales & Services | Shakas Educational Trust|IEEE projects | Research & Development | Journal Publication | Email : info@shakastech.com | shakastech@gmail.com | website: www.shakastech.com​ Facebook: https://www.facebook.com/pages/Shakas-Technologies

1. Base paper Title: Explainable Artificial Intelligence for Patient Safety: A Review of
Application in Pharmacovigilance
Modified Title: Understandable AI for Patient Safety: An Examination of Its Use in
Pharmacovigilance
Abstract
Explainable AI (XAI) is a methodology that complements the black box of artificial
intelligence, and its necessity has recently been highlighted in various fields. The purpose of
this research is to identify studies in the field of pharmacovigilance using XAI. Though there
have been many previous attempts to select papers, with a total of 781 papers being confirmed,
only 25 of them manually met the selection criteria. This study presents an intuitive review of
the potential of XAI technologies in the field of pharmacovigilance. In the included studies,
clinical data, registry data, and knowledge data were used to investigate drug treatment, side
effects, and interaction studies based on tree models, neural network models, and graph models.
Finally, key challenges for several research issues for the use of XAI in pharmacovigilance
were identified. Although artificial intelligence (AI) is actively used in drug surveillance and
patient safety, gathering adverse drug reaction information, extracting drug-drug interactions,
and predicting effects, XAI is not normally utilized. Therefore, the potential challenges
involved in its use alongside future prospects should be continuously discussed.
Existing System
The World Health Organization defines pharmacovigilance (PV) as the science and
activities related to the detection, assessment, understanding, and prevention of adverse effects
or other drug-related problems [1]. Recent artificial intelligence-based technologies can be an
efficient complement to traditional PV methods, which can be costly and time-consuming and
can result in adverse drug reactions (ADRs) that go unreported to healthcare professionals.
Artificial intelligence (AI) can improve PV, but its use in PV is still in the early stages of
research. Various machine learning (ML) techniques, together with natural language
processing and data mining, can be applied to electronic health records, claims databases and
social media data to improve the characterization of known drug side effects and reactions, and
to detect new signals [2], [3]. AI-based technologies have been criticized for their inexplicable
algorithms, despite their high predictive power. In critical decision areas such as healthcare,

2. the reasoning behind a decision is as important as the decision itself, which is why there is
growing interest in and research and development around Explainable Artificial Intelligence
(XAI). XAI was developed to improve the transparency of AI systems and generate
explanations for them, and seeks to increase trust and understanding by assessing the strengths
and limitations of existing models [4], [5], [6]. Approaches that extract information from a
model’s decision-making process, such as post-hoc explanations, can provide useful
information for practitioners and users interested in caseby-case explanations rather than the
internal workings of a model [7]. XAI increases the explainability and transparency of AI
algorithms by making it possible to interpret the variables that influence decisions, complex
internal features, and learned decision paths within a decision process [8], [9]. I.R. Ward et al.
successfully quantified the importance of features using an XAI algorithm, further
demonstrating the potential contribution of XAI to PV monitoring [10].
Drawback in Existing System
 Interpretability vs. Performance Trade-off:
There is often a trade-off between model interpretability and performance.
Simplifying a model for better interpretability might lead to a decrease in predictive
accuracy. Striking the right balance between model complexity and interpretability is a
crucial challenge.
 Limited Standardization:
Lack of standardized methods for explaining AI models in healthcare is a significant
drawback. The absence of uniform guidelines makes it difficult to compare different
XAI techniques and hinders widespread adoption.
 Dynamic Nature of Healthcare Data:
Healthcare data is dynamic and evolves over time. XAI models may struggle to adapt
to changes in patient profiles, treatment protocols, and disease patterns. The ability to
update models in real-time is a challenge that needs to be addressed.

3.  Resource Intensiveness:
Developing and maintaining XAI models can be resource-intensive. Many healthcare
organizations, especially smaller ones, may face challenges in terms of the expertise
and financial resources required for the implementation and upkeep of such systems.
Proposed System
 Data Collection and Preprocessing:
Collect and preprocess relevant patient data, including medical histories, treatment
records, and adverse event reports. Ensure data quality, address missing values, and
normalize variables.
 Feature Selection and Engineering:
Identify relevant features and potentially engineer new ones that contribute to the
predictive model. Feature engineering can enhance the model's ability to capture
important patterns in the data.
 Integration of XAI Techniques:
Implement XAI techniques to provide explanations for model predictions. This could
involve methods such as LIME, SHAP values, or attention mechanisms in neural
networks. The chosen technique depends on the selected model and the interpretability
requirements.
 Real-Time Monitoring and Alerts:
Implement a system for real-time monitoring of patient data and model predictions.
If adverse events or anomalies are detected, generate alerts for healthcare professionals
to intervene promptly.

4. Algorithm
 Decision Trees:
Decision trees are a straightforward and interpretable algorithm used in XAI. They
represent a series of decisions in a tree-like structure, where each node represents a
decision based on a specific feature. The path from the root to a leaf node represents
the decision process, making it easy to interpret.
 Logistic Regression:
Logistic Regression is a linear model commonly used for binary classification
problems. It estimates the probability of an event occurring based on input features. The
coefficients of the model can be interpreted to understand the impact of each feature on
the outcome.
 Neural Networks with Attention Mechanisms:
In deep learning, attention mechanisms have been incorporated into neural networks
to highlight the importance of specific input features. This can help make neural
networks more interpretable by showing which parts of the input data are crucial for a
particular prediction.
Advantages
 Enhanced Trust and Acceptance:
XAI provides clear and understandable explanations for its predictions or decisions,
fostering trust among healthcare professionals, regulatory bodies, and patients. The
transparency helps users better comprehend the AI system's reasoning, leading to
increased acceptance and confidence in its recommendations.
 Identification of Biases and Errors:
XAI algorithms can help uncover biases and errors in the data or the model itself.
By understanding how the model arrives at its decisions, stakeholders can identify and
address any biases that might exist in the training data, reducing the risk of biased or
discriminatory outcomes in patient safety decisions.

5.  Real-Time Monitoring and Adaptation:
XAI models can be designed to provide real-time explanations for their predictions.
This capability allows healthcare professionals to monitor changes in patient conditions
and treatment responses promptly. The adaptability of XAI systems can contribute to
more effective pharmacovigilance practices.
 Facilitates Continuous Improvement:
XAI promotes a continuous improvement cycle by allowing stakeholders to analyze
and refine models based on the provided explanations. This iterative process helps
enhance the accuracy and reliability of the AI system over time, aligning it more closely
with the evolving needs of patient safety in pharmacovigilance.
Software Specification
 Processor : I3 core processor
 Ram : 4 GB
 Hard disk : 500 GB
Software Specification
 Operating System : Windows 10 /11
 Frond End : Python
 Back End : Mysql Server
 IDE Tools : Pycharm